sitemap
Home
Membership
Meetings
Archives
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Canadian Hemophilia Registry
CHARMS
User Guides
Users Guide (v 3.0.1)
update (v3.1.0)
Generating Reports
Product Data Entry
Tracking Products SOP
ADR FAQs
Guide to ADR Reporting
Hemostatic Products available in Canada(Mar'09)
Newsletters
Issue 1
Issue 2
Issue 3
Issue 4
Issue 5
Issue 6
Issue 7
Issue 8
Issue 9
Issue 10
Patient Notification
Lab Facilities
Genetics Lab
Inhibitor Lab
Blood Borne Pathogens
Research
Committee
Publications & Giudelines
Rare Inherited Bleeding Disorders
Granting Agencies
Member Studies
Lit Searches
vWD
Bleeding Disorders in Women
Blood Components
Comprehensive Care
Family Involvement in Care
Genetic Counceling
Disease Management
Pre-Operative Assessment
Hemophiilia
Adjunctive Hemostatic Agents
Blood Components
Desmopressing side effects and therapy
Factor VIII Concentrates
Factor IX Concentrates
Factor IX side effects
Hemophilia A Diagnosis
Hemophilia B Diagnosis
Physiotherapy
Bleeding Disorders in Women
Member Log-In
AHCDC Publications
AHCDC Event Calendar
AHCDC ByLaws
Q & A
Studies:
Health related Quality of Life in Von Willebrand's Disease
Investigation of Clotting Factor Activity heterogeneity in Severe Hemophilia A